ImageneBio (IMA) Revenue (2020 - 2025)

ImageneBio has disclosed Revenue across 6 years of filings, most recently posting $800000.0 for Q1 2025.

• Revenue for Q1 2025 came in at $800000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $6.1 million (changed N/A YoY), and the FY2023 annual result was $9.2 million, down 41.35% from the prior year.
• Revenue came in at $800000.0 for Q1 2025 at ImageneBio, down from $3.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $20.2 million in Q4 2021 to a low of $382000.0 in Q2 2022.
• The 5-year median for Revenue is $3.5 million (2021), against an average of $4.3 million.
• Across the five-year window, Revenue surged 31003.08% in 2021 and tumbled 89.24% in 2022, its largest moves.
• ImageneBio's Revenue stood at $20.2 million in 2021, then slumped by 73.04% to $5.4 million in 2022, then slumped by 87.91% to $659000.0 in 2023, then surged by 431.11% to $3.5 million in 2024, then sank by 77.14% to $800000.0 in 2025.
• The last three Revenue figures came in at $800000.0 (Q1 2025), $3.5 million (Q3 2024), and $659000.0 (Q4 2023), per Business Quant data.